Emily E. Scott
Pharmacology, Toxicology and Pharmaceutics · University of Michigan
Publications
172
Citations
4,756
Est. group size
~5
Recurring co-author estimate
Active years
39
Publishing since 1988
Typically publishes in teams of ~3 · 55% small-team papers (≤3 authors) · across 35 venues
- 9 Genomic Testing Turnaround Times in Non-Small Cell Lung Cancer: A Regional Service Review
Lung Cancer · 2026
- 49 MRI head reporting in patients with Lung Cancer August 2024–2025
Lung Cancer · 2026
- Mass spectrometry footprinting reveals microsomal CYP2A6 structural changes induced by interaction with its reductase flavin mononucleotide domain
Drug Metabolism and Disposition · 2025
- Redox partner adrenodoxin induces substrate binding to steroidogenic cytochrome P450 11B2 and 11A1 by promoting a conformational change
Journal of Biological Chemistry · 2025
- Learning sport: a site-ontological practice theory perspective
Physical Education and Sport Pedagogy · 2025
- Cytochrome P450 2W1: Identification of new inhibitors, active site ligands, and pharmacophores
Journal of Biological Chemistry · 2025
- Research priorities in infection prevention and control in Alberta, Canada: a modified Delphi process
Journal of Hospital Infection · 2025
- Gliomas in adults: Guidance on investigations, diagnosis, treatment and surveillance
Clinical Medicine · 2024
- Development of a high throughput cytochrome P450 ligand-binding assay
Journal of Biological Chemistry · 2024
- Adrenodoxin allosterically alters human cytochrome P450 11B enzymes to accelerate substrate binding and decelerate release
RSC Chemical Biology · 2024
- Tracking protein–protein interactions by NMR: conformational selection in human steroidogenic cytochrome P450 CYP17A1 induced by cytochrome <i>b</i> <sub>5</sub>
Physical Chemistry Chemical Physics · 2024
- Biochemical Characterization of Human Cytochrome P450 7B1 Missense Mutations to Understand Spastic Paraplegia Type 5 Disease
Journal of Pharmacology and Experimental Therapeutics · 2024
- Redox Partner Adrenodoxin Allosterically Alters the Function of the Human Steroidogenic Cytochrome P450 11B Enzymes
Journal of Pharmacology and Experimental Therapeutics · 2024
- Structural Determination of Mutant FMN Containing Domain of Human Cytochrome P450 Reductase Using X-ray Crystallography
Journal of Pharmacology and Experimental Therapeutics · 2024
- Structural and Biochemical Characterization of CYP2D6-Mediated Dextromethorphan Metabolism Using Isonitrile-based Analogs
Journal of Pharmacology and Experimental Therapeutics · 2024
- Journal of Biological Chemistry×16
- The FASEB Journal×16
- Drug Metabolism and Disposition×8
- Journal of Pharmacology and Experimental Therapeutics×6
- Molecular and Cellular Endocrinology×2
- Haoming Zhang
Pharmacology, Toxicology and Pharmaceutics · University of Michigan
- Hwei‐Ming Peng
Pharmacology, Toxicology and Pharmaceutics · University of Michigan
- Hyunyoung Jeong
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
- Hao‐Jie Zhu
Pharmacology, Toxicology and Pharmaceutics · University of Michigan
- Aditi Shendre
Pharmacology, Toxicology and Pharmaceutics · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile